Improving Drug Discovery by Nucleic Acid Delivery in Engineered Human Microlivers
The liver plays a central role in metabolism; however, xenobiotic metabolism variations between human hepatocytes and those in model organisms create challenges in establishing functional test beds to detect the potential drug toxicity and efficacy of candidate small molecules. In the emerging areas...
Main Authors: | Mancio Silva, Liliana, Fleming, Heather, Miller, Alex B, Milstein, Stuart, Liebow, Abigail, Haslett, Patrick, Sepp-Lorenzino, Laura, Bhatia, Sangeeta N |
---|---|
Other Authors: | Massachusetts Institute of Technology. Institute for Medical Engineering & Science |
Format: | Article |
Language: | English |
Published: |
Elsevier BV
2020
|
Online Access: | https://hdl.handle.net/1721.1/128861 |
Similar Items
-
Controlled Apoptosis of Stromal Cells to Engineer Human Microlivers
by: Chen, Amanda X., et al.
Published: (2022) -
Engineered Livers for Infectious Diseases
by: Gural, Nil, et al.
Published: (2021) -
Peptides for nucleic acid delivery
by: Lehto, T, et al.
Published: (2016) -
Enhancing delivery of nucleic acid therapeutics (NATs)
by: Ong, Kai Hong
Published: (2021) -
Delivery of Proteins and Nucleic Acids: Achievements and Challenges
by: Reineke, Theresa M., et al.
Published: (2020)